(1 - 10 von 10
)
Der Atrial Flow Regulator (AFR) von Occlutech erhält die ...APA-OTS
www.ots.at
— "Für uns ist es ein wichtiger Meilenstein, diese bahnbrechende Auszeichnung zu erhalten", sagt Sabine Bois, Co-CEO der Occlutech Group.
Atrial Flow Regulator Receives FDA's Breakthrough Device ...
pulmonaryhypertensionnews.com
— “It is an important milestone for us to have received this breakthrough designation,” Sabine Bois, co-CEO of Occlutech Group, ... › ...
FDA grants Breakthrough Device Designation to Occlutech's ...
www.medicaldevice-network.com
— Occlutech Group Co-CEO Sabine Bois said: “It is an important milestone for us to have received this breakthrough designation. › ...
Occlutech AFR heart failure device obtains CE mark approval
www.dotmed.com
says Sabine Bois, Co-CEO of Occlutech AG. Additionally, she states that "the Occlutech AFR with its efficacy, versatility, convenience and safety ...
sortiert nach Relevanz / Datum